Avid Bioservices Inc (CDMO)

[biopharm]

The business model plan at Avid Bioservices now, needs clarification from our CEO Rick Hancock

Avid gets paid 15% royalties milestones manufacturing rights from the IP assets and with ALL KOLs having ties to Moffitt and affiliates ...in conjunction with Alan List and Thomas Sellers with 4 researchers under them fired/ resigned ....there is mounting evidence PS Targeting IP assets were involved

Even Jessica Frakes at Moffitt that wanted one of the NCCN trials and Moffitt ties with MD Anderson that also was part of the investigations

200 investigations

Thousands of emails monitored

Rick Hancock CEO can't just sit back and do nothing / say nothing ....what do they think that an announcement of a big contract to push us over $100M will make anyone forget ..

TGF beta-2 Targeting has flipped PS like Mateon OT101 just like the IP crosses over into Xencor

Maybe Heather Cox lawsuit against Peregrine then fleeing to Xencor with Steve Demattos meant other nefarious acts going on...

The researcher just busted in Boston was heading back to the sister institute of Moffitt...and now, things become more obvious that John Springs Stafford did not want PS Targeting to spoil Merck + Xencor relationships ...

All best continue to make those calls, with Alan List and Thomas Sellers removed, how many more are being paid off ?

Remember the patents from Scott Antonia....sold like a payoff to delay PS Targeting

Moffitt Cancer Center in FL ties to Peregrine Pharmaceuticals KOL Dmitry Gabrilovich / Scott Antonia / Jessica Frakes etc etc etc

_____

MD Anderson and Sun Yat-Sen University Cancer Center

https://mdanderson.elsevierpure.com/en/organisations/sun-yat-sen-university-cancer-center-sysucc/network-organisations/

____


SYSUCC has established collaborative and friendly relationships with many renowned international institutes from around the world.[18]

SYSUCC has been a sister institute with MD Anderson Cancer Center since 2003. The purpose is to create collaborative oncology research projects between MDACC and other sister institutes in the fight against cancer.[19][20][21]

In 2004, SYSUCC set up a joint laboratory with the Karolinska Institutet of Sweden for research in immunotherapy, molecular virology and oncological epidemiology.

SYSUCC signed a Memorandum of Understanding (MoU) with the UK’s University of Warwick in 2015, creating a partnership in cancer diagnosis, care and research. SYSUCC and the University of Warwick are exploring opportunities in regards to digital pathology, nursing, and anti-cancer drug research.[22][23]

In 2017, SYSUCC and Fred Hutchinson Cancer Research Center signed a broad five-year Memorandum of Understanding to carryout research on cancer diagnosis and treatment.[24][25]

https://en.m.wikipedia.org/wiki/Sun_Yat-sen_University_Cancer_Center